Biological cell processing chip
Latest NanoCav, LLC Patents:
- Devices and methods for mitochondria replacement and for generating cellular therapeutics
- Methods of transfection for large cargo using poly(beta-amino esters)
- Mechanical transfection devices and methods
- Microfluidic cellular device and methods of use thereof
- Micro flow-through electroporation devices and methods of cell transfection
The broken lines in
Claims
The ornamental design for a biological cell processing chip, as shown and described.
5955028 | September 21, 1999 | Chow |
6074605 | June 13, 2000 | Meserol et al. |
6969604 | November 29, 2005 | Yakovenko |
D621060 | August 3, 2010 | Handique |
D669191 | October 16, 2012 | Handique |
D879999 | March 31, 2020 | Wronko |
11046976 | June 29, 2021 | Wu |
20040197883 | October 7, 2004 | Dzekunov et al. |
20050118705 | June 2, 2005 | Rabbitt et al. |
20060057245 | March 16, 2006 | Haupt |
20090166201 | July 2, 2009 | Tian |
20100216126 | August 26, 2010 | Balachandran |
20130256132 | October 3, 2013 | Chen |
20140332377 | November 13, 2014 | Su |
20170010259 | January 12, 2017 | Amoabediny |
20170037357 | February 9, 2017 | Cattaruzzi et al. |
20170240945 | August 24, 2017 | Marquant |
20170283761 | October 5, 2017 | Corso |
20190136224 | May 9, 2019 | Garcia Dominguez et al. |
20200017847 | January 16, 2020 | Chang |
20200221987 | July 16, 2020 | Liu |
20200238282 | July 30, 2020 | Burns |
20200249232 | August 6, 2020 | Konstantopoulos |
20200340014 | October 29, 2020 | Chang |
20220025402 | January 27, 2022 | Chang et al. |
20220088604 | March 24, 2022 | Yu |
101928666 | April 2013 | CN |
103451097 | December 2013 | CN |
106995783 | August 2017 | CN |
208250332 | December 2018 | CN |
D2019-7688 | February 2020 | JP |
WO-2006112870 | October 2006 | WO |
WO-2020014264 | January 2020 | WO |
WO-2021007315 | January 2021 | WO |
- How microfluidics can automate drug discovery and development. Online, published day May 17, 2021. Retrieved on Sep. 11, 2022 from URL: https://www.drugtargetreview.com/article/91542/how-microfluidics-can-automate-drug-discovery-and-development/.
- Book Chapter on Design and Fabrication of Microfluidic Devices Published. Online, published date Aug. 26, 2021. Retrieved on May 20, 2023 from URL: https://people.sutd.edu.sg/˜hashimoto/book-chapter-on-design-and-fabrication-of-microfluidic-devices-published/.
- High flow rate microfluidic device for blood plasma separation using a range of temperatures. Online, published date 2010. Retrieved on May 20, 2023 from URL: https://pubs.rsc.org/en/content/articlelanding/2010/lc/b904531g.
- Andresen et al., “Injection molded chips with integrated conducting polymer electrodes for electroporation of cells,” Journal of Micromechanics and Microengineering, 20: 1-9 (2010).
- Boissel, L., et al., “Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells,” Leuk Res., 33(9): 1255-1259 (2009).
- Choi et al., “A high throughput microeletroporatin device to introduce a chimeric antigen receptor to redirect the specificity of human T cells,” Biomed Microdevices, 12: 855-863 (2010).
- Ding et al., “High-throught neclear delivery and repid expression of DNA via mechanical and electrical cell-membrane disruption,” Nature biomedical engineering, 1(39): 1-7 (2017).
- Examination Report from corresponding Australian Application No. 2020311908 dated Feb. 10, 2022.
- International Preliminary Report on Patentability from PCT Application No. PCT/US2019/041055 dated Sep. 15, 2020.
- International Search Report from corresponding PCT Application No. PCT/US2020/041188 dated Oct. 21, 2020.
- International Search Report from PCT Application No. PCT/US2019/041055 dated Sep. 23, 2019.
- Jiang, W., et al., “Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL,” Cytotherapy, 10(3): 265-274 (2008).
- Li, S., “Electroporation Protocols: Preclinical and clinical gene medicine,” Shulin Li (Ed.), Methods in Molecular Biology, 423: 1-511 (2008).
- MaxCyte, “ExPERT GTx,” (2020).
- MaxCyte, “EXPERT STx,” (2020).
- MaxCyte, “MaxCyte VLX® Large-Scale Transfection System,” (2017).
- Moffett, H.F., et al., “Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers,” Nature Communications, 8(389): 1-13 (2017).
- Office Action from corresponding Japanese Application No. 2021-501021 dated Apr. 5, 2022.
- Office Action from corresponding U.S. Appl. No. 16/506,190 dated Sep. 16, 2021.
- Selmeczi et al., “Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip,” Biomed Microdevices, 13: 383-392 (2011).
- Selmeczi et al., “Large scale mRNA Transfection of Dendritic Cells by Electroporation in Ccontinuous Flow Systems,” Methods in Molecular Biology, 1428 (Chapter 10) :151-161 (2016).
- Wei, Z., et al., “A Laminar Flow Electroporation System for Efficient DNA and siRNA Delivery,” Analytical Chemistry, 83: 5881-5887 (2011).
- Written Opinion from corresponding PCT Application No. PCT/US2020/041188 dated Oct. 21, 2020.
- Written Opinion from PCT Application No. PCT/US2019/041055 dated Sep. 23, 2019.
- Young, J.L. & Dean, D.A., “Electroporation-Mediated Gene Delivery,” Adv. Genet, 89: 49-88 (2015).
- Zhao, D., et al., “A Flow-Through Cell Electroporation Device for Rapidly and Efficiently Transfecting Massive Amounts of Cells in vitro and ex vivo , ” Scientific Reports, 6: 1-9 (2016).
Type: Grant
Filed: Oct 20, 2021
Date of Patent: Feb 27, 2024
Assignee: NanoCav, LLC (Culver City, CA)
Inventors: Chihwei Chang (Los Angeles, CA), Wade Richardson (Los Angeles, CA), Artin Mehrabi (Burbank, CA)
Primary Examiner: Omeed Agilee
Application Number: 29/812,292